Skip to Content

EVOLVE II

The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)

Patient Information

The purpose of this study is to assess the safety and effectiveness of the SYNERGY Everolimus-Eluting Platinum Chromium Coronary Stent System for the treatment of subjects with atherosclerotic lesion(s) ≤ 34 mm in length (by visual estimate) in native coronary arteries ≥2.25 mm to ≤4.0 mm in diameter (by visual estimate).

More details at: http://clinicaltrials.gov/ct2/show/NCT01665053

Study Number
NCT01665053

Clinical Trial Categories

  • PCI Trials: Devices